Expression of CD56 Is an Independent Prognostic Factor to Predict Relapse in Acute Myeloid Leukemia with t(8;21): Results of Japan Adult Leukemia Study Group (JALSG) AML97 Protocol.
Noriyoshi Iriyama(Nihon University), Tomoki Naoe(National Hospital Organization), Masatomo Takahashi(Shiga University of Medical Science), Sumihisa Honda(Nagasaki University), Tomoya Maeda(Saitama Medical University), Yoshihiro Hatta(Nihon University), Kinuko Mitani(The University of Tokyo), Yasushi Miyazaki(Nagasaki University), Hisashi Sakamaki(Tokyo Metropolitan Komagome Hospital), Fumihiro Ishida(Shinshu University), Tomohiko Taki(Kyorin University), Tohru Izumi(Niigata Prefectural Niigata Minami High School), Yoshiaki Ogawa(Tokai University), Shuichi Miyawaki(Tokyo Metropolitan Ohtsuka Hospital), Jin Takeuchi(Nihon University), Shigeki Ohtake(Kanazawa University), Masafumi Taniwaki(Kyoto Prefectural University), Toru Sakura(Gunma Saiseikai Maebashi Hospital)
Cited by 0
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k